Immunosuppressant Drugs
- All
- News
-
Glenmark Pharma Gets Regulatory Nod For Tacrolimus Capsules; Stock Gains Nearly 2%
Glenmark Pharma received final approval from USFDA for Tacrolimus capsules, which are used as immunosuppressants to prevent human immune system from rejecting liver, kidney and heart transplants.
-
Seaweed Capsules To Bring Insulin Injection-Free Life
Seaweed capsules may lead to an injection-free life for diabetic patients, say researchers who have developed a novel method to overcome major challenges in pancreatic islet transplantation.
-
Dr Reddy's Launches Generic Immunosuppressant Tablets in US
Dr Reddy's Laboratories said on Tuesday that it has launched a generic version of Wyeth's Rapamune tablets, an immunosuppressant, in the US market.
-
US sues Novartis, alleging kickbacks to pharmacies
U.S. Attorney Preet Bharara in Manhattan said Novartis had since 2005 induced at least 20 pharmacies to switch thousands of kidney transplant patients to its immunosuppressant drug Myfortic from competitors' drugs, in exchange for kickbacks disguised as rebates and discounts.
-
HPV infection raises skin cancer risk
Human papilloma virus (HPV) infection increases the risk of developing certain skin cancers and the risk is worse if people are taking immunosuppressive drugs.
-
Glenmark Pharma Gets Regulatory Nod For Tacrolimus Capsules; Stock Gains Nearly 2%
Glenmark Pharma received final approval from USFDA for Tacrolimus capsules, which are used as immunosuppressants to prevent human immune system from rejecting liver, kidney and heart transplants.
-
Seaweed Capsules To Bring Insulin Injection-Free Life
Seaweed capsules may lead to an injection-free life for diabetic patients, say researchers who have developed a novel method to overcome major challenges in pancreatic islet transplantation.
-
Dr Reddy's Launches Generic Immunosuppressant Tablets in US
Dr Reddy's Laboratories said on Tuesday that it has launched a generic version of Wyeth's Rapamune tablets, an immunosuppressant, in the US market.
-
US sues Novartis, alleging kickbacks to pharmacies
U.S. Attorney Preet Bharara in Manhattan said Novartis had since 2005 induced at least 20 pharmacies to switch thousands of kidney transplant patients to its immunosuppressant drug Myfortic from competitors' drugs, in exchange for kickbacks disguised as rebates and discounts.
-
HPV infection raises skin cancer risk
Human papilloma virus (HPV) infection increases the risk of developing certain skin cancers and the risk is worse if people are taking immunosuppressive drugs.
